Back

Safety and feasibility of drug eluting and perfusion therapy for left main disease: JDEPTH-LM pilot study

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Improving techniques and devices for better outcomes in percutaneous coronary interventions Technique ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Takayuki Warisawa

NTT Medical Center Tokyo, Tokyo (Japan)

7 More presentations in this session

Presentation thumbnail
A retrospective study on real world, 2-stent left main bifurcation PCI using DK crush technique with IVUS guidance - a single center experience
Doctor K. Kaniappan (Kuala Lumpur, MY)
Abstract Slides Video
Presentation thumbnail
OSDOKINA crush technique for the management of side branch ostial lesion ISTANBOL study
Associate Professor I. Donmez (Bolu, TR)
Abstract Slides Video
Presentation thumbnail
Side branch interventions late after MFM implantation
Doctor P. Polomski (Sofia, BG)
Abstract Slides Video
Presentation thumbnail
Biolimus A9 DEB for the Treatment of In-Stent Restenosis. 1-year outcomes of the REFORM trial.
Doctor R. Durand (Dublin, IE)
Abstract Slides Video
Presentation thumbnail
Does initial use of large versus small burr size in left main stem bifurcation impact clinical and procedural outcomes?
Doctor A. Alatta (Newcastle-Upon-Tyne, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Improving techniques and devices for better outcomes in percutaneous coronary interventions

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Clinical impact of perfusion balloon for ST-segment elevated myocardial infarction: RYUSEI study
thumbnail
Congress Presentation
Double kissing mini-crush technique for the treatment of coronary bifurcation lesions: step by step analysis of technical success, procedural times and required resources
thumbnail
Congress Presentation
OSDOKINA crush technique for the management of side branch ostial lesion ISTANBOL study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources